SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and N

Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewe

TRAW

Related stories